封面
市場調查報告書
商品編碼
1738269

胚胎植入前基因檢測市場-全球產業規模、佔有率、趨勢、機會及預測,依流程、產品、技術、應用、最終用戶、區域及競爭細分,2020-2030 年預測

Preimplantation Genetic Testing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Procedure, By Product, By Technology, By Application, By End User, By Region & Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球植入前基因檢測市值為 6.553 億美元,預計到 2030 年將達到 10.5387 億美元,預測期內的複合年成長率為 8.20%。植入前基因檢測 (PGT) 是輔助生殖技術中的關鍵程序,主要用於體外受精 (IVF) 期間植入前篩檢胚胎是否有基因異常。 PGT 的兩種主要類型包括 PGT-A(用於識別染色體非整倍體)和 PGT-M(用於檢測單基因疾病)。這種檢測可以提高成功懷孕的機會,並降低傳播遺傳性疾病的風險。由於 PGT 能夠改善胚胎選擇和降低遺傳風險,因此在全球範圍內越來越受歡迎,尤其是在具有已知遺傳傾向的夫婦中。人們的認知不斷提高、基因診斷技術的進步以及生育服務機會的增加正在推動這一市場的擴張。

市場概覽
預測期 2026-2030
2024年市場規模 6.553億美元
2030年市場規模 10.5387億美元
2025-2030 年複合年成長率 8.20%
成長最快的領域 植入前基因診斷(PGD)
最大的市場 歐洲

關鍵市場促進因素

遺傳性疾病發生率上升

主要市場挑戰

倫理道德關懷

主要市場趨勢

提供胚胎植入前基因檢測 (PGT) 服務的生育診所數量不斷增加

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:胚胎植入前基因檢測市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依程序(植入前基因篩檢、植入前基因診斷)
    • 按產品(試劑及耗材、儀器、軟體)
    • 依技術(次世代定序 (NGS)、聚合酶鍊式反應 (PCR)、螢光原位雜合技術 (FISH)、其他)
    • 依應用(染色體異常、X 連鎖疾病、胚胎檢測、非整倍體篩檢、HLA 分型、其他)
    • 按最終使用者(生育中心、醫院、診斷中心、研究中心和學術實驗室)
    • 按地區
    • 按公司分類(2024)
  • 市場地圖

第6章:北美胚胎植入前基因檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲胚胎植入前基因檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第8章:亞太地區胚胎植入前基因檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲胚胎植入前基因檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東與非洲胚胎植入前基因檢測市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章:全球植入前基因檢測市場:SWOT 分析

第 14 章:競爭格局

  • California Pacific Medical Center (CPMC)
  • CombiMatrix Corp
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings

第 15 章:策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 13099

The Global Preimplantation Genetic Testing Market was valued at USD 655.30 Million in 2024 and is projected to reach USD 1053.87 Million by 2030, growing at a CAGR of 8.20% during the forecast period. Preimplantation Genetic Testing (PGT) is a pivotal procedure within assisted reproductive technologies, primarily used during in vitro fertilization (IVF) to screen embryos for genetic abnormalities prior to implantation. The two key types of PGT include PGT-A, which identifies chromosomal aneuploidies, and PGT-M, which detects monogenic disorders. This testing enhances the chances of a successful pregnancy and reduces the risk of transmitting hereditary diseases. With its capacity to improve embryo selection and mitigate genetic risks, PGT is gaining traction globally, especially among couples with known genetic predispositions. Growing awareness, advancements in genetic diagnostics, and increased access to fertility services are fueling the expansion of this market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 655.30 Million
Market Size 2030USD 1053.87 Million
CAGR 2025-20308.20%
Fastest Growing SegmentPre-implantation genetic diagnosis (PGD)
Largest MarketEurope

Key Market Drivers

Rising Incidence of Genetic Disorders

A major factor propelling the preimplantation genetic testing market is the increasing prevalence of genetic disorders across global populations. These conditions affect a significant percentage of live births and early-life diagnoses, with approximately 5.3% of individuals worldwide being diagnosed with a genetic condition by age 25. This rising incidence has heightened the demand for early detection and intervention solutions, particularly among couples with hereditary risk factors. In regions such as the Middle East and North Africa, where consanguineous marriages are prevalent, the uptake of PGT is particularly strong due to elevated genetic risks. PGT offers a proactive approach to identifying embryos unaffected by hereditary diseases, improving reproductive outcomes and reducing long-term healthcare burdens. Its adoption is further supported by growing public and clinical awareness about genetic disorders and their impact on offspring health.

Key Market Challenges

Ethical And Moral Concern

Ethical and moral concerns surrounding the use of PGT remain a prominent challenge in the market. The technology's potential to enable selection based on non-medical traits-such as physical appearance or cognitive abilities-raises fears of societal discrimination and the possible emergence of "designer babies." These concerns fuel debates about fairness, equity, and human diversity. Additionally, the screening and possible discarding of embryos with genetic conditions is a contentious issue, particularly in societies where abortion and embryo manipulation are morally or religiously opposed. Such dilemmas pose regulatory hurdles and may limit acceptance and accessibility in certain regions, thereby restraining the market's growth despite its clinical potential.

Key Market Trends

Growing Number of Fertility Clinics Offering Preimplantation Genetic Testing (PGT) Services

An expanding network of fertility clinics offering PGT services is a notable trend boosting market accessibility and growth. As these clinics extend their reach into diverse geographies, patients in both urban and remote areas gain improved access to advanced reproductive and genetic services. The integration of PGT into fertility clinic offerings enhances the convenience of comprehensive care by combining IVF and genetic diagnostics under one roof. This growing availability fosters competitive service provision, technological innovation, and cost efficiencies. Furthermore, broader adoption of PGT in clinical settings is accelerating advancements in testing accuracy, turnaround times, and scope, including the ability to detect an expanded range of genetic abnormalities-thereby improving patient outcomes and expanding the market's potential.

Key Market Players

  • California Pacific Medical Center (CPMC)
  • CombiMatrix Corp
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Genea Limited
  • Genesis Genetics
  • Good Start Genetics, Inc.
  • IGENOMIX
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings

Report Scope:

In this report, the Global Preimplantation Genetic Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Preimplantation Genetic Testing Market, By Procedure:

  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis

Preimplantation Genetic Testing Market, By Product:

  • Reagents and Consumables
  • Instruments
  • Software

Preimplantation Genetic Testing Market, By Technology:

  • Next Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescent In-Situ Hybridization (FISH)
  • Others

Preimplantation Genetic Testing Market, By Application:

  • Chromosomal Abnormalities
  • X-linked Diseases
  • Embryo Testing
  • Aneuploidy Screening
  • HLA Typing
  • Other

Preimplantation Genetic Testing Market, By End User:

  • Fertility Centers
  • Hospitals
  • Diagnostic Centers
  • Research Centers and Academic Labs

Preimplantation Genetic Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Preimplantation Genetic Testing Market.

Available Customizations:

Global Preimplantation Genetic Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Preimplantation Genetic Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Procedure (Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis)
    • 5.2.2. By Product (Reagents and Consumables, Instruments, Software)
    • 5.2.3. By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In-Situ Hybridization (FISH), Others)
    • 5.2.4. By Application (Chromosomal Abnormalities, X-linked Diseases, Embryo Testing, Aneuploidy Screening, HLA Typing, Other)
    • 5.2.5. By End User (Fertility Centers, Hospitals, Diagnostic Centers, Research Centers and Academic Labs)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Preimplantation Genetic Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Procedure
    • 6.2.2. By Product
    • 6.2.3. By Technology
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Preimplantation Genetic Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Procedure
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Technology
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Preimplantation Genetic Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Procedure
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Technology
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Preimplantation Genetic Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Procedure
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Technology
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Preimplantation Genetic Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Procedure
    • 7.2.2. By Product
    • 7.2.3. By Technology
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Preimplantation Genetic Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Procedure
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Technology
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. United Kingdom Preimplantation Genetic Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Procedure
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Technology
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. Italy Preimplantation Genetic Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Procedure
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Technology
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. France Preimplantation Genetic Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Procedure
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Technology
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Preimplantation Genetic Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Procedure
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Technology
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia-Pacific Preimplantation Genetic Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Procedure
    • 8.2.2. By Product
    • 8.2.3. By Technology
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Preimplantation Genetic Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Procedure
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Technology
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Preimplantation Genetic Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Procedure
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Technology
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Preimplantation Genetic Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Procedure
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Technology
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Preimplantation Genetic Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Procedure
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Technology
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Preimplantation Genetic Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Procedure
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Technology
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. South America Preimplantation Genetic Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Procedure
    • 9.2.2. By Product
    • 9.2.3. By Technology
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Preimplantation Genetic Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Procedure
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Technology
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. Argentina Preimplantation Genetic Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Procedure
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Technology
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. Colombia Preimplantation Genetic Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Procedure
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Technology
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. Middle East and Africa Preimplantation Genetic Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Procedure
    • 10.2.2. By Product
    • 10.2.3. By Technology
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Preimplantation Genetic Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Procedure
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Technology
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Saudi Arabia Preimplantation Genetic Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Procedure
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Technology
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. UAE Preimplantation Genetic Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Procedure
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Technology
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Preimplantation Genetic Testing Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. California Pacific Medical Center (CPMC)
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. CombiMatrix Corp
  • 14.3. CooperSurgical, Inc.
  • 14.4. F. Hoffmann-La Roche Ltd.
  • 14.5. Genea Limited
  • 14.6. Genesis Genetics
  • 14.7. Good Start Genetics, Inc.
  • 14.8. IGENOMIX
  • 14.9. Illumina, Inc.
  • 14.10.Invitae Corporation
  • 14.11.Laboratory Corporation of America Holdings

15. Strategic Recommendations

16. About Us & Disclaimer